series-c-plus
Stage
1
Investors
About
Orthogem Ltd develops synthetic bone graft substitutes using their patented Tripore technology, which produces fully resorbable hydroxyapatite granules that are replaced by natural bone.
Explore Orthogem's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.